Abnormal expression of PPARα may be related to a variety of metabolic disorders including fatty liver, alcoholic cardiomyopathy, atherosclerosis, etc. In tumours, PPARα is reported to be involved in mediating tumour proliferation, invasion and metastasis. The gene discussed is PPARA; the disease is metabolic disease.